“… 8 The current N-staging has a poor ability to discriminate between patients for survival, and the number of positive LNs (pLNs) may be useful in the assessment of LN metastatic burden. 10 , 11 In addition, several pieces of evidence suggested that adequate lymph node testing is more conducive to the prognostic assessment. 12 , 13 Therefore, previous studies have constructed some indicators to evaluate the LN status of lung cancer, such as positive LN Ratio (LNR), pLNs, and the Log Odds of positive LNs (LODDS).…”